Molecular Diagnosis & Therapy

Papers
(The H4-Index of Molecular Diagnosis & Therapy is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
ADORA3: A Key Player in the Pathogenesis of Intracranial Aneurysms and a Potential Diagnostic Biomarker131
The Role of MicroRNAs in the Pathogenesis and as Biomarkers for Pediatric Epilepsy: A Systematic Review90
Predictive Ability of Serum Amino Acid Levels to Differentiate Fibromyalgia Patients from Healthy Subjects79
Comment on “Prognostic and Clinical Significance of Human Leukocyte Antigen Class I Expression in Breast Cancer: A Meta‑Analysis”79
Personalized Cancer Monitoring Assay for the Detection of ctDNA in Patients with Solid Tumors55
Indirect Clinical Validation of a Programmed Death-Ligand 1 Laboratory-Developed Test for Gastric/Gastroesophageal Junction Adenocarcinoma with 22C3 Antibody Concentrate55
A Window of Opportunity for Newborn Screening53
Gene Therapy for Cardiomyocyte Renewal: Cell Cycle, a Potential Therapeutic Target39
Personalized Medicine in Cystic Fibrosis: Characterization of Eight Rare CFTR Variants in Intestinal Organoids and Cellular Models36
FAPI-Targeted Molecular Imaging: Transforming Insights into Post-Ischemic Myocardial Remodeling?36
Evaluation of Minimal Residual Disease in Patients with Neuroblastoma35
Drug Hypersensitivity Reactions in Patients with Cystic Fibrosis: Potential Value of the Lymphocyte Toxicity Assay to Assess Risk32
Expression Signature of Immune-Related MicroRNAs in Autoimmune Skin Disease: Psoriasis and Vitiligo Insights32
The Role of Non-coding RNAs in Connective Tissue Diseases: Diagnostic and Therapeutic Potential of miRNAs, lncRNAs and circRNAs31
Prediction of Biomarker Expression on Primary Pancreatic Ductal Adenocarcinoma Tissues Using Fine-Needle Biopsies: Paving the Way for a Patient-Tailored Molecular Imaging Approach31
Research Progress on Signal Conversion Based on Aptamer Combined CRISPR/Cas System in Biosensors30
Correction to: Revakinagene Taroretcel: First Approval30
Fatty Acid Desaturase: The Yin or Yang of Disease Pathology28
Development of a Nomogram to Predict Therapeutic Resistance in Metastatic Melanoma Using Longitudinal ctDNA Kinetics25
Inflammatory Gene Panel Guiding the Study of Genetics in Inflammatory Bowel Disease24
Personalizing Oncolytic Immunovirotherapy Approaches24
Recent Advancements in Nanomaterials: A Promising Way to Manage Neurodegenerative Disorders23
Advances and Challenges in the Diagnosis of Leishmaniasis23
0.042948007583618